Positron Corporation Announces New Corporate Headquarters and Strategic Redomiciling to Delaware

26th August, 2025

The new headquarters will house corporate operations and serve as a product showroom and testing centre

Positron Corporation, a leader in molecular imaging technology and services, announced that the Company had established a new corporate headquarters in the Buffalo-Niagara Falls region, and that its Board of Directors has approved the redomiciling of the Company from Texas to Delaware.

Signed under a long-term lease, the new headquarters will house corporate operations and serve as a product showroom and testing centre. This expanded space is also expected to support Positron’s accelerated growth initiatives, enhance customer engagement, and provide new operational capabilities – enabling faster scaling of the Company’s PET-CT imaging solutions nationwide.

Further supporting the Company’s growth strategy, Positron’s redomiciling to the State of Delaware is aimed at enhancing the Company’s corporate governance and legal framework as it prepares to file a Form 10 registration statement with the U.S. Securities and Exchange Commission to become a fully reporting public company.

“These steps forward mark an exciting new chapter in Positron’s evolution,” said Positron President Adel Abdullah. “Our strengthened corporate structure and expanded facility support our growth and reinforce our ability to advance our strategic goals and deliver greater long-term value to our customers and shareholders.”

Medtech Special

© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer